Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

BioNxt Solutions (BXT) Stock Price & Analysis

BXT Stock Chart & Stats

€0.19€0.01(3.85%)
At close: 5:30 PM GMT+1
€0.175€0.2€0.2253 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
EUR 0.18 - EUR 0.19
52-Week Range
EUR 0.17 - EUR 0.55
Previous Close
EUR 0.18
Volume
10.42K
Average Volume (3M)
23.73K
Market Cap
EUR 22.67M
Enterprise Value
EUR 49.67M
Total Cash (Recent Filing)
EUR 1.20M
Total Debt (Recent Filing)
EUR 6.69M
Price to Earnings (P/E)
―
Beta
0.61
Next Earnings
Nov 27, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Improving Asset Base

The increase in total assets during the trailing twelve months provides a modest improvement in the company’s resource base. While it does not resolve negative equity or solvency concerns, asset growth could support operations if paired with a credible path to revenue generation and better capital discipline.

Reduced Cash Burn

The reduction in operating cash burn suggests some improvement in cash management compared with the prior period. However, cash generation remains negative, so the benefit is incremental rather than transformative; sustained improvement would be necessary to reduce external funding needs over coming quarters.

Losses Below Earlier Peaks

The fact that losses were larger in earlier years indicates that deterioration is not uniformly worsening across the full historical record. This offers limited evidence of some historical improvement in cost or loss control, although current zero revenue means the earnings profile remains highly fragile.

Bears Say

Revenue Collapse

Revenue has effectively disappeared from the reported business, falling from 372k in 2023 to zero in both 2025 and the trailing twelve months. Without meaningful sales, the company has little operating scale to absorb expenses, making recovery dependent on restoring commercial activity.

Persistent Losses And Cash Burn

Large ongoing losses combined with negative operating and free cash flow show that the business is not currently self-funding. Continued cash burn can require additional external financing, while the absence of positive earnings or cash generation limits flexibility to invest in growth and sustain operations.

Stressed Capitalization

Negative shareholder equity and debt that substantially exceeds the asset base indicate severe balance-sheet strain. This capitalization structure reduces financial flexibility, complicates access to sustainable funding, and leaves the company more exposed to financing pressure while revenue and cash generation remain weak.

BioNxt Solutions News

BXT FAQ

What was BioNxt Solutions’s price range in the past 12 months?
BioNxt Solutions lowest stock price was €0.17 and its highest was €0.55 in the past 12 months.
What is BioNxt Solutions’s market cap?
BioNxt Solutions’s market cap is €22.67M.
When is BioNxt Solutions’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were BioNxt Solutions’s earnings last quarter?
BioNxt Solutions released its earnings results on Aug 28, 2026. The company reported -€0.006 earnings per share for the quarter.
Is BioNxt Solutions overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does BioNxt Solutions pay dividends?
BioNxt Solutions does not currently pay dividends.
What is BioNxt Solutions’s EPS estimate?
BioNxt Solutions’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioNxt Solutions have?
BioNxt Solutions has 136,093,150 shares outstanding.
What happened to BioNxt Solutions’s price movement after its last earnings report?
BioNxt Solutions reported an EPS of -€0.006 in its last earnings report. Following the earnings report the stock price went up 6.818%.
Which hedge fund is a major shareholder of BioNxt Solutions?
Currently, no hedge funds are holding shares in DE:BXT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology